From symbiosis to immunity: the evolutionary revival of mitochondrial defense programs in inflammatory diseases.
Level 5 - mechanism / opinion, no new human data
Narrative review presenting a theoretical mechanistic framework without new empirical human data.
PubMed 41776601 · doi:10.1186/s12964-026-02736-z
What was done
The authors synthesized evolutionary, structural, and immunometabolic literature to propose the Mitochondrial Endosymbiotic Dysregulation (MED) framework, describing the progressive transition of mitochondria from metabolic contributors to immune activators during inflammatory stress.
What was found
No quantitative data are reported in the abstract. The paper describes a qualitative three-stage model: MED-I (adaptive remodeling with morphological structures like mitoFLARE and mito-donut), MED-II (functional collapse featuring mito-matryoshka structures), and MED-III (structural disintegration, rupture, and release of mitochondrial damage-associated molecular patterns triggering innate immune cascades).
Why it matters
The framework reframes mitochondrial dysfunction in diseases such as sepsis, autoimmunity, and neuroinflammation as an active reactivation of ancient bacterial defense programs rather than passive cellular damage.
Limits
The abstract describes a narrative review and theoretical model without empirical human measurements, quantitative syntheses, or primary experimental data. Clinical utility and the proposed morphological stages require validation in patient populations.
Cited by
- supports Mitochondria originated evolutionarily from bacteria and possess distinct DNA inherited maternally.